The first microchip was invented in Texas in the 1950s, but many of today’s most advanced chips are made in Taiwan and South Korea. Last week, the U.S. government purchased a 10% stake in the ...

PDS Biotechnology (PDSB) announced final topline survival data from its VERSATILE-002 Phase 2 clinical trial. VERSATILE-002 evaluated PDS0101 + Keytruda in patients with HPV16-positive first-line ...

DUBLIN, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

Microsoft has backed out of building data centers, Intel's factory opening has been delayed to 2030, but one tech industry is going strong in central Ohio: Biotechnology. The now multibillion dollar ...

Nykode Therapeutics has designed a two-year plan to turn its fortunes around. Having lost a deal with Genentech—and with the future of a Regeneron pact uncertain—the Norwegian biotech is focusing on ...

TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner’s 2025 Hype Cycle for Data Center Infrastructure Technologies LAS VEGAS--(BUSINESS ...

A California-based cancer biotech, Exelixis, is closing a laboratory in King of Prussia and laying off 130 people, the company said Wednesday. Less than two years after Exelixis expanded to the ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

Fosun Pharma has penned its third inflammatory disease pact in three weeks, plucking up China rights to a clinical-stage treatment from Accro Bioscience. Shanghai-based Fosun is putting down 60 ...

New Taipei City, Taiwan, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to ...

Gross profit margin was 40.8%, an increase of 6.3 percentage point Net profit amounted to RMB148.6 million, increased by 3.1% YoY Adjusted non-IFRS net profit reached RMB183.5 million, increased by ...